Kyle Apley

Dr. Kyle Apley

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2021 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Closed access
KAKyle Apley
Kyle Apley
ALAmy D. Laflin
Amy D. Laflin
SJStephanie N. Johnson
Stephanie N. Johnson
NBNoora Batrash
Noora Batrash
JGJ. Daniel Griffin
J. Daniel Griffin
BDBrandon J DeKosky
Brandon J DeKosky

25 October 2022 in ACS Pharmacology & Translational Science
Verified
Journal Article
Closed access
AHAric Huang
Aric Huang
SKSuresh E. Kurhade
Suresh E. Kurhade
PRPatrick Ross
Patrick Ross
KAKyle Apley
Kyle Apley
JGJonathan Daniel Griffin
Jonathan Daniel Griffin
Mark P. FarrellMark P. Farrell
Mark P. Farrell

26 October 2023 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
KAKyle Apley
Kyle Apley
AGAmber S. Griffith
Amber S. Griffith
GDGrant M. Downes
Grant M. Downes
PRPatrick Ross
Patrick Ross
Mark P. FarrellMark P. Farrell
Mark P. Farrell
CBCory Berkland
Cory Berkland

6 July 2023 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
SJStephanie N. Johnson
Stephanie N. Johnson
SBSpencer D. Brucks
Spencer D. Brucks
KAKyle Apley
Kyle Apley
Mark P. FarrellMark P. Farrell
Mark P. Farrell
CBCory Berkland
Cory Berkland

23 April 2026 in JCI Insight
Verified
Journal Article
Open access
CGCamillo Bechi Genzano
Camillo Bechi Genzano
GZGiorgia Zanetti
Giorgia Zanetti
QDQian Du
Qian Du
DTDaniel Traum
Daniel Traum
DLDeeksha Lahori
Deeksha Lahori
RCRemi Creusot
Remi Creusot
Stem cell–derived β cells offer a promising approach for type 1 diabetes (T1D) treatment. However, the processes of graft infiltration and rejection by immune cells remain poorly understood in humans. In this study, autologous or allogeneic stem cell–derived islets (SC-islets) were transplanted in human immune system mice and analyzed 14 to 18 weeks later. Imaging mass cytometry revealed unique characteristics of SC-islet grafts, including a high percentage of glucagon + cells and the presence of cysts and CD57 + enterochromaffin cells, features not typically observed in endogenous or transplanted allogeneic primary pancreatic islets. Allogeneic SC-islet grafts exhibited heavy immune infiltration, cell proliferation, and pro-fibrotic processes, whereas autologous grafts showed minimal infiltration and little fibrosis. In some mice, autologous T cells expressing islet antigen-reactive (IAR) T cell receptors (TCRs) were adoptively transferred. Three weeks after transfer, autologous grafts injected with IAR-TCR + T cells showed negligible immune infiltration, even though IAR-TCR + T cells were detected in the spleen. Under the conditions tested, human SC-islet grafts were not rejected by an autologous immune system, even in the presence of autoreactive T cells, pointing to several limitations that remain to be addressed for a model of spontaneous autologous SC-islet infiltration and destruction.

4 February 2026 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
GDGrant M. Downes
Grant M. Downes
CGCamillo Bechi Genzano
Camillo Bechi Genzano
CSColin R. Silva
Colin R. Silva
KAKyle Apley
Kyle Apley
RCRemi J. Creusot
Remi J. Creusot
CBCory Berkland
Cory Berkland